4//SEC Filing
STEINMETZ MICHAEL 4
Accession 0001209191-12-032788
CIK 0001339455other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 3:44 PM ET
Size
16.5 KB
Accession
0001209191-12-032788
Insider Transaction Report
Form 4
SIMON NICHOLAS J III
10% Owner
Transactions
- Sale
Common Stock
2012-06-06$0.29/sh−8,400$2,436→ 3,783,185 total(indirect: See Footnote) - Sale
Common Stock
2012-06-05$0.29/sh−29,555$8,571→ 3,791,585 total(indirect: See Footnote)
WHEELER KURT
Director
Transactions
- Sale
Common Stock
2012-06-06$0.29/sh−8,400$2,436→ 3,783,185 total(indirect: See Footnote) - Sale
Common Stock
2012-06-05$0.29/sh−29,555$8,571→ 3,791,585 total(indirect: See Footnote)
GADICKE ANSBERT
10% Owner
Transactions
- Sale
Common Stock
2012-06-06$0.29/sh−8,400$2,436→ 3,783,185 total(indirect: See Footnote) - Sale
Common Stock
2012-06-05$0.29/sh−29,555$8,571→ 3,791,585 total(indirect: See Footnote)
GALAKATOS NICHOLAS
10% Owner
Transactions
- Sale
Common Stock
2012-06-05$0.29/sh−29,555$8,571→ 3,791,585 total(indirect: See Footnote) - Sale
Common Stock
2012-06-06$0.29/sh−8,400$2,436→ 3,783,185 total(indirect: See Footnote)
EVNIN LUKE
10% Owner
Transactions
- Sale
Common Stock
2012-06-05$0.29/sh−29,555$8,571→ 3,791,585 total(indirect: See Footnote) - Sale
Common Stock
2012-06-06$0.29/sh−8,400$2,436→ 3,783,185 total(indirect: See Footnote)
HENNER DENNIS
10% Owner
Transactions
- Sale
Common Stock
2012-06-05$0.29/sh−29,555$8,571→ 3,791,585 total(indirect: See Footnote) - Sale
Common Stock
2012-06-06$0.29/sh−8,400$2,436→ 3,783,185 total(indirect: See Footnote)
STEINMETZ MICHAEL
10% Owner
Transactions
- Sale
Common Stock
2012-06-05$0.29/sh−29,555$8,571→ 3,791,585 total(indirect: See Footnote) - Sale
Common Stock
2012-06-06$0.29/sh−8,400$2,436→ 3,783,185 total(indirect: See Footnote)
Footnotes (4)
- [F1]The shares were sold as follows: 24,636 by MPM BioVentures III-QP, L.P. ("BV III QP"), 1,657 by MPM BioVentures III, L.P. ("BV III"), 436 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 744 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 2,082 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
- [F2]The shares are held as follows: 3,160,532 by BV III QP, 212,518 by BV III, 55,987 by AM 2005, 95,470 by BV Parallel and 267,078 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
- [F3]The shares were sold as follows: 7,002 by BV III QP, 471 by BV III, 124 by AM 2005, 211 by BV Parallel and 592 by BV KG.
- [F4]The shares are held as follows: 3,153,530 by BV III QP, 212,047 by BV III, 55,863 by AM 2005, 95,259 by BV Parallel and 266,486 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001166285
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 3:44 PM ET
- Size
- 16.5 KB